do glp-1 agonists have cardiovascular benefit Glucagon-like peptide 1 receptor agonists: benefits and mechanisms of action GLP-1 receptor agonists (GLP-1RAs): cardiovascular

Studies were excluded if they focused on pediatric populations, only reported emergency procedures, lacked a control group of GLP-1RA nonusers, or used limited International Classification of Diseases, Tenth Revision, and Clinical Modification (ICD-10-CM) codes for aspiration outcomes

[DOI] [PubMed] [Google Scholar] 39.Varner VD, Taber LA

Nakashima S, Matsui T, Takeuchi M, Yamagishi S-I

Administration: Administer via subcutaneous injection in preclinical models using calibrated syringes

Lastly, the systemic effects of GLP-1RAs, such as body weight loss [103] and potential reduction in muscle mass [104], pose significant challenges for elderly individuals with neurodegenerative diseases

You can also contact your Blue Cross and Blue Shield of Kansas representative.